Article Type
Changed
Fri, 11/02/2018 - 07:24
Display Headline
Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?
Article PDF
Author and Disclosure Information

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Issue
Cleveland Clinic Journal of Medicine - 70(1)
Publications
Topics
Page Number
64-65
Sections
Author and Disclosure Information

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Author and Disclosure Information

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 70(1)
Issue
Cleveland Clinic Journal of Medicine - 70(1)
Page Number
64-65
Page Number
64-65
Publications
Publications
Topics
Article Type
Display Headline
Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?
Display Headline
Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media